Dementia is becoming one of the biggest health challenges facing the world today. As people live longer, the number of older adults developing memory and thinking problems continues to rise.
Dementia affects millions of families worldwide and places a heavy emotional and financial burden on healthcare systems and caregivers.
Alzheimer’s disease is the most common type of dementia. It slowly damages brain cells and can lead to memory loss, confusion, poor judgment, personality changes, and difficulty carrying out daily tasks. In the later stages, many people need full-time care.
One of the hardest parts about dementia is that it often develops silently for many years before symptoms become obvious. By the time someone notices serious memory problems, the brain may already have experienced major damage.
Because of this, scientists have been trying to find easier ways to detect dementia risk much earlier. Early detection could allow people to receive treatment sooner, make healthy lifestyle changes, plan future care, and possibly slow disease progression.
Now, researchers from the University of Exeter believe they may have found a simple and practical solution that can be done entirely from home.
Their new study shows that a finger-prick blood test combined with online memory and thinking tests may help identify people at higher risk of dementia without requiring hospital visits or complicated medical scans.
The research was published in the journal Nature Communications. The paper is titled “Alzheimer’s Disease blood biomarkers measured through remote capillary sampling correlate with cognition in older adults.”
The study was led by Professor Anne Corbett from the University of Exeter Medical School.
Researchers focused on two important proteins found in blood samples. One protein, called Ptau 217, is strongly linked to Alzheimer’s disease. The second protein, called Gfap, is associated with more general brain decline and damage.
Scientists now believe these proteins may act as biomarkers. Biomarkers are measurable signs inside the body that may help doctors detect disease before symptoms become severe.
To test the new approach, the team worked through the online PROTECT study, a large research project involving more than 30,000 adults in the United Kingdom aged over 40.
Participants in PROTECT regularly complete online tests designed to measure memory, attention, concentration, and decision-making ability.
For this part of the study, 174 participants were sent finger-prick blood collection kits that they used themselves at home. After collecting a small blood sample, they mailed it back to researchers for analysis.
The results showed a strong connection between blood protein levels and performance on the online cognitive tests.
People with higher levels of the dementia-linked proteins generally performed worse on tests involving memory and thinking skills. Among the two proteins, Ptau 217 showed the strongest relationship with declining cognitive performance.
Using the combined information from blood tests and brain testing, researchers were able to group participants into low-risk, medium-risk, and high-risk categories for dementia.
The findings suggest that this kind of at-home screening could eventually become a powerful tool for identifying people who may need further medical evaluation.
At the moment, diagnosing dementia often requires specialist appointments, brain scans, long waiting times, and detailed cognitive assessments. Many people are diagnosed late because early symptoms can be subtle or mistaken for normal aging.
Researchers believe home-based screening could make early detection easier, faster, and more affordable.
Professor Corbett explained that earlier studies had already shown that blood collected through finger-prick testing could successfully measure proteins linked to dementia. This new research strengthens those findings by showing the protein levels also match changes in thinking and memory ability.
The researchers say the approach could help healthcare systems focus resources more effectively.
People at high risk could receive earlier specialist care, monitoring, and treatment. Those at lower risk could avoid unnecessary stress and testing. People at moderate risk could receive guidance about lifestyle changes that may help protect brain health in the future.
Scientists are especially interested in early diagnosis because newer Alzheimer’s treatments may work best during the earliest disease stages before large amounts of brain damage occur.
Professor Clive Ballard from the University of Exeter Medical School said current healthcare systems often fail to identify people early enough. He noted that many individuals with early cognitive decline never receive specialist assessment until symptoms become much worse.
Researchers believe at-home testing could help reach large numbers of people who would otherwise not be prioritized for evaluation.
The approach may also reduce pressure on hospitals and clinics by allowing many tests to be completed remotely.
Still, scientists caution that more research is needed before the method can become part of routine healthcare.
The blood-testing portion of the study involved a relatively small number of participants, and larger studies are needed to confirm how accurate the method is across different populations.
Researchers must also study whether factors such as age, other illnesses, medications, and education levels affect the test results.
Even so, the findings represent an important step toward simpler and more accessible dementia screening.
The study highlights how advances in blood testing and online technology may eventually transform the way brain diseases are detected and managed.
If future studies confirm the results, at-home testing may one day allow millions of people to check their dementia risk early and receive support long before severe symptoms appear.
If you care about brain health, please read studies about how the Mediterranean diet could protect your brain health, and blueberry supplements may prevent cognitive decline.
For more health information, please see recent studies about antioxidants that could help reduce dementia risk, and Coconut oil could help improve cognitive function in Alzheimer’s.
Source: University of Exeter.
